Kristian Humer - 30 Jul 2021 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Director
Signature
/s/ Mark Ballantyne (Attorney-in-Fact)
Issuer symbol
SNSE
Transactions as of
30 Jul 2021
Net transactions value
$0
Form type
4
Filing time
02 Aug 2021, 16:20:34 UTC
Previous filing
27 Jul 2021
Next filing
03 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNSE Stock Option (Right to Buy) Award $0 +16,667 $0.000000 16,667 30 Jul 2021 Common Stock 16,667 $7.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth (1/36th) of the shares underlying the option granted shall vest and become exercisable each month following July 30, 2021, over three years such that the options shall be 100% vested on July 30, 2024, subject to the grantee's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through each such vesting date.